Rapamycin-induced oligomer formation system of FRB-FKBP fusion proteins.

[1]  T. Inobe,et al.  Artificial regulation of p53 function by modulating its assembly. , 2015, Biochemical and biophysical research communications.

[2]  B. Cui,et al.  Optogenetic control of intracellular signaling pathways. , 2015, Trends in biotechnology.

[3]  J. Saez-Rodriguez,et al.  A rapidly reversible chemical dimerizer system to study lipid signaling in living cells. , 2014, Angewandte Chemie.

[4]  A. Deiters,et al.  Optical control of protein function through unnatural amino acid mutagenesis and other optogenetic approaches. , 2014, ACS chemical biology.

[5]  Martin J. Lohse,et al.  G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives , 2014, Pharmacological Reviews.

[6]  Neil P King,et al.  Practical approaches to designing novel protein assemblies. , 2013, Current opinion in structural biology.

[7]  Takanari Inoue,et al.  Rapidly reversible manipulation of molecular activity with dual chemical dimerizers. , 2013, Angewandte Chemie.

[8]  Wilfried Weber,et al.  Optogenetic tools for mammalian systems. , 2013, Molecular bioSystems.

[9]  Carsten Schultz,et al.  Protein translocation as a tool: The current rapamycin story , 2012, FEBS letters.

[10]  I. Choi,et al.  Direct monitoring of the inhibition of protein-protein interactions in cells by translocation of PKCδ fusion proteins. , 2011, Angewandte Chemie.

[11]  B. White,et al.  Chemically controlled protein assembly: techniques and applications. , 2010, Chemical reviews.

[12]  Fabrizio Chiti,et al.  A causative link between the structure of aberrant protein oligomers and their toxicity. , 2010, Nature chemical biology.

[13]  S. Simmonds,et al.  SOLUBLE DI‐ AND AMINOPEPTIDASES IN ESCHERICHIA COLI K‐12 Dispensible Enzymes , 2009 .

[14]  R. Morimoto,et al.  Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. , 2008, Genes & development.

[15]  O. Mayans,et al.  A regular pattern of Ig super-motifs defines segmental flexibility as the elastic mechanism of the titin chain , 2008, Proceedings of the National Academy of Sciences.

[16]  R. Siegel,et al.  Chemically controlled self-assembly of protein nanorings. , 2006, Journal of the American Chemical Society.

[17]  Barbara Imperiali,et al.  Protein oligomerization: how and why. , 2005, Bioorganic & medicinal chemistry.

[18]  Tobias Meyer,et al.  An inducible translocation strategy to rapidly activate and inhibit small GTPase signaling pathways , 2005, Nature Methods.

[19]  Corey W. Liu,et al.  Characterization of the FKBP.rapamycin.FRB ternary complex. , 2005, Journal of the American Chemical Society.

[20]  Jennifer J. Kohler,et al.  Regulating cell surface glycosylation by small molecule control of enzyme localization. , 2003, Chemistry & biology.

[21]  Jennifer E. Padilla,et al.  Nanohedra: Using symmetry to design self assembling protein cages, layers, crystals, and filaments , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A J Olson,et al.  Structural symmetry and protein function. , 2000, Annual review of biophysics and biomolecular structure.

[23]  T. Davison,et al.  Characterization of the oligomerization defects of two p53 mutants found in families with Li–Fraumeni and Li–Fraumeni-like syndrome , 1998, Oncogene.

[24]  S. Schreiber,et al.  Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Shannon R. Magari,et al.  A humanized system for pharmacologic control of gene expression , 1996, Nature Medicine.

[26]  S. Schreiber,et al.  Dimeric ligands define a role for transcriptional activation domains in reinitiation , 1996, Nature.

[27]  A. Pastore,et al.  Immunoglobulin-like modules from titin I-band: extensible components of muscle elasticity. , 1996, Structure.

[28]  S. Schreiber,et al.  Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Schreiber,et al.  A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase , 1989, Nature.

[30]  K. Stankunas,et al.  Rapamycin analogs with differential binding specificity permit orthogonal control of protein activity. , 2006, Chemistry & biology.